| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/14/2011 | US20110171174 Synergistic Combinations of a Macrocyclic Inhibitor of HCV and a Nucleoside |
| 07/14/2011 | US20110171172 Compounds for inhibiting ksp kinesin activity |
| 07/14/2011 | US20110171167 Isocyanate-Based Compositions and Their Use |
| 07/14/2011 | US20110171159 Glycoside Derivatives and Uses Thereof |
| 07/14/2011 | US20110171157 Non-spherical fine particles, method of production thereof and cosmetic materials and resin compositions containing same |
| 07/14/2011 | US20110171156 Topical Scar Treatment Composition |
| 07/14/2011 | US20110171143 Method of maintaining oral health in animals |
| 07/14/2011 | US20110171142 Metformin glycinate salt for blood glucose control |
| 07/14/2011 | US20110171140 Absorption of therapeutic agents across mucosal membranes or the skin |
| 07/14/2011 | US20110171139 Fasudil in combination therapies for the treatment of pulmonary arterial hypertension |
| 07/14/2011 | US20110171138 Substantially pure deferasirox and processes for the preparation thereof |
| 07/14/2011 | US20110171130 A3 adenosine receptor antagonists and partial agonists |
| 07/14/2011 | US20110171127 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
| 07/14/2011 | DE102010004431A1 Pathogenesis of migraine, which is the causal therapy in the removal of perivascular edema of the dura-vascular of the brain using acetazolamide to treat migraine pain |
| 07/14/2011 | CA2823974A1 Methods and compositions for the treatment of migraine headaches |
| 07/14/2011 | CA2804034A1 Prodrugs of heteraromatic compounds |
| 07/14/2011 | CA2790197A1 Stabilized formulations containing anti-interleukin-6 receptor (il-6r) antibodies |
| 07/14/2011 | CA2786777A1 Obesity small molecules |
| 07/14/2011 | CA2786686A1 Enhanced bone healing |
| 07/14/2011 | CA2786603A1 Fumagillol type compounds and methods of making and using same |
| 07/14/2011 | CA2786598A1 Topical transdermal dexmedetomidine compositions and methods of use thereof |
| 07/14/2011 | CA2786535A1 Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg |
| 07/14/2011 | CA2786534A1 Arylsulfonamide pyridine-pyridinone derivatives, preparation of same, and therapeutic use thereof |
| 07/14/2011 | CA2786525A1 Methods and compositions for applying moxifloxacin to the ear |
| 07/14/2011 | CA2786424A1 Raf kinase inhibitors |
| 07/14/2011 | CA2786328A1 Treatment method |
| 07/14/2011 | CA2786319A1 Bisphenol derivatives and their use as androgen receptor activity modulators |
| 07/14/2011 | CA2786289A1 Methods and compositions of targeted drug development |
| 07/14/2011 | CA2786277A1 Methods and compositions of targeted drug development |
| 07/14/2011 | CA2786266A1 A combination of an immunomodulatory compound and an artemisinin or a derivative thereof for treating cancer |
| 07/14/2011 | CA2786233A1 Anti-inflammatory analgesic adhesive patch for external use |
| 07/14/2011 | CA2786072A1 Sulfone compounds as 5-ht6 receptor ligands |
| 07/14/2011 | CA2786056A1 Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene |
| 07/14/2011 | CA2786026A1 Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent |
| 07/14/2011 | CA2785998A1 Darunavir polymorph and process for preparation thereof |
| 07/14/2011 | CA2785920A1 Solid oral dosage form containing olmesartan medoxomil |
| 07/14/2011 | CA2785876A1 Novel benzoic pyrrolopyridine derivatives |
| 07/14/2011 | CA2785834A1 Fatty acid derivatives and analogs of drugs |
| 07/14/2011 | CA2785822A1 Methods of providing weight loss therapy in patients with major depression |
| 07/14/2011 | CA2785204A1 Hedgehog inhibitors |
| 07/14/2011 | CA2785200A1 Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetate, and uses thereof |
| 07/14/2011 | CA2785037A1 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 07/14/2011 | CA2784921A1 Salts and crystalline forms of a factor xa inhibitor |
| 07/14/2011 | CA2784908A1 Combination, kit and method of reducing intraocular pressure |
| 07/14/2011 | CA2784906A1 Anti-heparin compounds |
| 07/14/2011 | CA2784904A1 Methods of synthesizing factor xa inhibitors |
| 07/14/2011 | CA2784772A1 Mesalamine suppository |
| 07/14/2011 | CA2784744A1 Compound |
| 07/14/2011 | CA2784667A1 Mglu2 agonists |
| 07/14/2011 | CA2784647A1 Inhibitors of sphingosine kinase |
| 07/14/2011 | CA2784601A1 Implantable device with intravesical tolerability and methods of treatment |
| 07/14/2011 | CA2784580A1 Homogeneous suspension of immunopotentiating compounds and uses thereof |
| 07/14/2011 | CA2784492A1 Non-irritating ophthalmic povidone-iodine compositions |
| 07/14/2011 | CA2784407A1 Abuse-resistant formulations |
| 07/14/2011 | CA2784118A1 Micro-rna regulation in ischemia and ischemia-reperfusion injury |
| 07/14/2011 | CA2784028A1 Method of treating atrial fibrillation |
| 07/14/2011 | CA2783882A1 Piperazines as antimalarial agents |
| 07/14/2011 | CA2783468A1 Ppar-sparing thiazolidinedione salts for the treatment of metabolic diseases |
| 07/14/2011 | CA2783264A1 Ppar-sparing thiazolidinediones and combinations for the treatment of diabetes mellitus and other metabolic diseases |
| 07/14/2011 | CA2783262A1 Ppar-sparing thiazolidinediones and combinations for the treatment of obesity and other metabolic diseases |
| 07/14/2011 | CA2782366A1 Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1 |
| 07/14/2011 | CA2782347A1 Quinoline amide m1 receptor positive allosteric modulators |
| 07/14/2011 | CA2782085A1 Dp2 antagonist and uses thereof |
| 07/14/2011 | CA2782075A1 Nestorone/estradiol transdermal gel |
| 07/14/2011 | CA2781576A1 Combination preparation including a corticosteroid and exosomes |
| 07/14/2011 | CA2781223A1 Combination preparation including a cytokine antagonist and corticosteroid |
| 07/14/2011 | CA2780821A1 Mmp-13 inhibitors for the treatment of periodontitsis |
| 07/13/2011 | EP2343384A2 Method for diagnosing non-small cell lung cancer |
| 07/13/2011 | EP2343310A1 Serine hydrolase formulation |
| 07/13/2011 | EP2343306A1 Glycolipid derivatives, process for production of the same, intermediates for synthesis thereof, and process for production of the intermediates |
| 07/13/2011 | EP2343304A1 Biocidal boronophthalide compounds |
| 07/13/2011 | EP2343303A1 PI3-kinase inhibitors |
| 07/13/2011 | EP2343302A1 Tricyclic pyrazole derivatives as cannabinoid receptor modulators |
| 07/13/2011 | EP2343299A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/13/2011 | EP2343298A1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors |
| 07/13/2011 | EP2343297A1 Triazolopyridines |
| 07/13/2011 | EP2343296A1 A process for the purification of paliperidone |
| 07/13/2011 | EP2343295A1 Triazolopyridine derivates |
| 07/13/2011 | EP2343294A1 Substituted triazolopyridines |
| 07/13/2011 | EP2343293A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof |
| 07/13/2011 | EP2343292A1 Novel prostaglandin i<sb>2</sb>derivative |
| 07/13/2011 | EP2343291A1 3-(Indolyl)- or 3-(Azaindolyl)-4-arylmaleimide compounds and their use in tumor treatment |
| 07/13/2011 | EP2343290A1 Diamine derivatives as factor X inhibitors |
| 07/13/2011 | EP2343289A1 Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent |
| 07/13/2011 | EP2343287A1 New 2-aminothiadiazole derivatives |
| 07/13/2011 | EP2343282A1 Diaminopyrimidines as P2X3 and P2X2/3 antagonists |
| 07/13/2011 | EP2343279A1 Fused-ring derivative and medical application of same |
| 07/13/2011 | EP2343273A1 Novel type i natural ceramide derivative and method for producing same |
| 07/13/2011 | EP2343089A1 Utilization of xylitol or its derivatives for taste-masking chemotherapy drugs of the quinolone-o-naphthyridone carboxylic acid group administrated in food intended for pigs |
| 07/13/2011 | EP2343088A1 Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis |
| 07/13/2011 | EP2343086A2 Antibodies to CD40 |
| 07/13/2011 | EP2343078A1 Light-stabilized pharmaceutical composition |
| 07/13/2011 | EP2343077A1 Derivatives of totally N-desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 07/13/2011 | EP2343076A1 Pharmaceutical composition for oral administration |
| 07/13/2011 | EP2343075A1 Diazoxide for use in the treatment a central nervous system (CNS) autoimmune demyelinating disease |
| 07/13/2011 | EP2343074A1 Use of purine analogues for treating airway diseases |
| 07/13/2011 | EP2343073A2 Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| 07/13/2011 | EP2343072A1 Remedy |
| 07/13/2011 | EP2343071A1 Pharmaceutical dosage forms |
| 07/13/2011 | EP2343070A1 Pirfenidone treatment for patients with atypical liver function |